Nadine
Nadine Abi-Jaoudeh, Washington, DC US
Patent application number | Description | Published |
---|---|---|
20150150466 | IMAGING THERMOMETRY - A computing device includes a thermal map generator ( | 06-04-2015 |
Nadine Bizouarne, Schiltigheim FR
Patent application number | Description | Published |
---|---|---|
20090104156 | PHARMACEUTICAL COMPOSITIONS FOR TREATING PAPILLOMAVIRUS TUMORS AND INFECTION - A pharmaceutical composition for treating or preventing a papillomavirus infection or tumour, including, as the therapeutical agents, a polypeptide from an early region and a polypeptide from a late region of a papillomavirus, optionally combined with a polypeptide having immunostimulatory activity or a polypeptide from an early or late region of a papillomavirus and a polypeptide having immunostimulatory activity, or alternatively, a recombinant vector containing inserted DNA fragments coding for the above-mentioned polypeptide combinations. | 04-23-2009 |
Nadine Bouby, Paris FR
Patent application number | Description | Published |
---|---|---|
20150105329 | Methods and Pharmaceutical Compositions for Prevention or Treatment of Ischemia Related Organ Damage - The present invention relates to methods and compositions for the prevention or treatment of ischemia related organ damage. | 04-16-2015 |
Nadine Bremeyer, Cambridgeshire GB
Patent application number | Description | Published |
---|---|---|
20110053940 | 3,4-SUBSTITUTED PIPERIDINE DERIVATIVES AS RENIN INHIBITORS - The present invention relates to 3,4-substituted piperidinyl-based renin inhibitor compounds bearing at 4-position oxopyridine and having the formula (I). The invention further relates to pharmaceutical compositions containing said compounds, as well as their use in treating cardiovascular events and renal insufficiency. | 03-03-2011 |
Nadine Bremeyer, Hoddesdon GB
Patent application number | Description | Published |
---|---|---|
20140107346 | PROCESS FOR PREPARING CHIRAL DIPEPTIDYL PEPTIDASE-IV INHIBITORS - A process for the preparation of pyrazolopyrolidines of structural formula I: and W is or P, wherein in P is an amine protecting group. These compounds are useful in the synthesis of dipeptidyl peptidase-IV inhibitors for the treatment of Type 2 diabetes. Also provided are useful intermediates obtained from the process. | 04-17-2014 |
Nadine Buard, Meudon FR
Patent application number | Description | Published |
---|---|---|
20100148790 | METHOD AND DEVICE FOR CHARACTERISING SENSITIVITY TO ENERGY INTERACTIONS IN AN ELECTRONIC COMPONENT - To analyse an electric component in depth, provision is made to submit said component to focused laser radiation. It is shown that by modifying the altitude of the focus in the component, some internal parts of said component can be characterized more easily. | 06-17-2010 |
20100280785 | METHOD FOR TESTING A SOFTWARE APPLICATION - To test a software application, a method submits an electronic board including a component implementing an application to a laser radiation generated in test equipment. The component is excited with laser pulses having very short durations distributed during complex operational phases of the component for running the application, and the reaction of the component and the application are observed. | 11-04-2010 |
20100289501 | METHOD FOR CHARACTERIZING THE SENSITIVITY OF AN ELECTRONIC COMPONENT TO ENERGETIC INTERACTIONS - The behavior of a component subjected to pulsed laser radiation is measured. The polarization value, frequency, and temperature (or other operating conditions) to which the component is sensitive are determined by detecting a temporary or permanent fault in the operation of the component. If necessary, the parasitic currents generated are prevented from destroying the tested component at the time of testing. A susceptibility of the component to energetic interactions and the preferred operating conditions for the component are deduced. | 11-18-2010 |
20110043245 | COMPONENT PROVIDED WITH AN INTEGRATED CIRCUIT COMPRISING A CRYPTOROCESSOR AND METHOD OF INSTALLATION THEREOF - In order to protect an integrated circuit provided with a cryptoprocessor from attacks aiming to reveal secrets, it is anticipated to use a component sensitive to the activation of a parasitic (latchup) thyristor and/or to the activation of a parasitic bipolar transistor, or to design a circuit having this property. If the component is stressed due to the presence of this circuit, it is immediately deactivated, actually preventing the revelation of the secrets thereof. | 02-24-2011 |
20110298332 | ELECTRIC GENERATOR EXCITED BY IONIZING RADIATIONS - The invention relates to an electric generator sensitive to ionizing radiation produced by the reverse mounting of a diode in parallel between a reverse polarization stack and a pulse converter or only with a pulse converter. A generator is thus provided that can be used inside a spacecraft or in the atmosphere by using cosmic radiation, or in an environment containing ionizing radiation such as in the medical or nuclear fields, and which is preferably directly mounted on a printed circuit board receiving a remote sensor. | 12-08-2011 |
20120284006 | METHOD OF DETERMINING THE PARTICLE SENSITIVITY OF ELECTRONIC COMPONENTS - To analyze an electronic component, this component is exposed to a focused laser beam. The information provided by the laser mapping relating to the position and to the depth of the sensitivity zones of the component is used as input parameter in prediction codes for quantifying the sensitivity of the mapped component to ionizing particles in the natural radioactive environment. The prediction codes are used to determine the occurrence of malfunctions in the electronic component. Determination of the risks associated with the radiative environment imposes two aspects: one, probabilistic, takes into account the particle/matter interaction and the other, electrical, takes into account the charge collection inside the electronic component. | 11-08-2012 |
20150141852 | Detection Device for Bedding for Sleep Monitoring - A detection device, for placement under or on a mattress, configured for the movements of a person lying on the mattress, includes a sensing portion having an inflatable chamber intended to be positioned under the individual, an electronic unit arranged at a distance from the sensing portion and having a pressure sensor, intended to be positioned outside of the bedding, a transmitting portion interposed between the sensing portion and the electronic unit, including a channel establishing a fluid connection between the inflatable chamber and the sensor, the channel having a transverse dimension (T) that is much smaller than the width (L | 05-21-2015 |
20150160068 | Weighing Device and Method - Electronic scale including four feet, four strain gauges, an electronic control unit and a display, where the gauges are combined in pairs in first and second Wheatstone bridge type circuits, where a first intermediate-point of the bridge is selectively connected via a switch to an intermediate voltage source and where the first and second outputs of the amplifiers are summed by the electronic control unit in order to deduce therefrom a weight for an object present on the device, with indication for the user of off-center condition on the scale. Weighing method implemented in such a scale. | 06-11-2015 |
Nadine Chapman-Rothe, London GB
Patent application number | Description | Published |
---|---|---|
20150057263 | Quinazoline Compounds And Their Use In Therapy - This invention relates to quinazoline compounds of Formula (I) which are inhibitors of the histone lysine methyltransferase (HKMTase) EZH2, and to uses of such compounds as medicaments, in particular in the treatment of a disease or disorder in which inhibition of EZH2 provides a therapeutic or prophylactic effect. | 02-26-2015 |
Nadine Charni-Ben Tabassi, Villeurbanne FR
Patent application number | Description | Published |
---|---|---|
20100233737 | MARKER SPECIFIC TO AN OXIDATIVE DEGRADATION OF TISSUES CONTAINING TYPE III COLLAGEN, MEANS AND METHODS AND KITS FOR THE DIAGNOSIS, MONITORING OR PROGNOSIS OF PATHOLOGIES TARGETED BY THIS MARKER - Novel peptide marker, specific to the oxidative degradation of tissues containing type III collagen, preferably to nitrosylation of the type III collagen. This marker is defined of at least one peptide sequence of 5 to 25 amino acids (AAs) including a sub-sequence QYDSYD in which at least one of the Ys is nitrosylated and Q corresponds not only to glutamine but also to pyroglutamic acid. This marker is simple, sensitive and reliable and expedites the clinical information for obtaining oxidative degradation of tissues containing type III collagen (O.D.T.Coll III) pathologies. This marker allows better monitoring, prognosis and treatment of the O.D.T.Coll III pathologies. This invention concerns also elements of detection of the marker, methods and kits which allow, on one hand, the early, reliable, efficient and economical diagnosis of the pathologies targeted and, on the other hand, improved monitoring and prognosis of the O.D.T.Coll III pathologies. | 09-16-2010 |
Nadine Chomarat, Fayssac FR
Patent application number | Description | Published |
---|---|---|
20120225936 | METHOD FOR PRODUCING TRIPTOLIDE - The invention relates to a method for producing triptolide from a suspension cell culture of | 09-06-2012 |
20130172289 | METHOD FOR THE PREPARATION OF SODIUM CHONDROITIN SULPHATE - The present invention concerns a method for obtaining sodium chondroitin sulphate from cartilage, notably of avian origin, as well as a sodium chondroitin sulphate preparation. | 07-04-2013 |
Nadine Cino, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110169617 | METHODS AND SYSTEMS FOR IDENTIFYING STACKED SETS AND LOCATING AND TRACKING STACKED SETS - One embodiment of the present invention is a method for determining when a set of RFID tags on a set of stacked objects belongs to a same defined subset of stacked objects (“set identification”). This method includes the steps of: (1) detecting the set of RFID tags on the set of stacked objects, said RFID tags comprising integrated devices capable of sending signals that can be received by a receptor device and interpreted to determine a motion state of each RFID tag and stacked object; (2) receiving said signals from the set of RFID tags; (3) interpreting said signals to determine the motion state of each RFID tag and stacked object within the set, wherein said signals indicate whether the motion state of each RFID tag and object is in a state of stationary, starting in motion, stopping in motion, or continuing in motion; (4) determining which RFID tags and objects are in a same motion state within a predetermined time of each other; and (5) identifying the RFID tags that are in the same motion state, within the predetermined time, as belonging to the same defined subset of stacked objects, wherein said motion state is used to determine when said set of stacked objects forms a new stack. | 07-14-2011 |
20120169478 | PORTABLE RFID BASE STATION FOR IDENTIFYING, DETECTING, LOCATING, AND TRACKING TAGGED OBJECTS - One embodiment of the invention is a portable RFID base station for detecting, locating and tracking tagged items. The base station is constructed of an outer housing that includes a set of vertical sidewalls, a horizontal bottom floor, and a horizontal top lid, as well as a set of wheels beneath the floor allowing the portable RFID base station to be moved. The base station includes a battery for supplying electrical power to the base station system components, an RFID reader for wirelessly communicating with a set of RFID tags, a cellular modem for communicating with a remote server, a computer system, and a router for communicating between the processor, the RFID reader, and the cellular modem. The portable RFID base station may be used to assist with tracking objects during office and household relocation, record storage, trucking, freight, train and rail transportation, air transportation, and logistics. | 07-05-2012 |
Nadine Collaert, Blanden BE
Patent application number | Description | Published |
---|---|---|
20090020786 | SEMICONDUCTOR DEVICE - A method for forming a semiconductor device on a substrate having a first major surface lying in a plane and the semiconductor device are disclosed. In one aspect, the method comprises, after patterning the substrate to form at least one structure extending from the substrate in a direction substantially perpendicular to a major surface of the substrate, forming locally modified regions at locations in the substrate not covered by the structure, thus locally increasing etching resistance of these regions. Forming locally modified regions may prevent under-etching of the structure during further process steps in the formation of the semiconductor device. | 01-22-2009 |
20090159972 | METHOD OF FABRICATING MULTI-GATE SEMICONDUCTOR DEVICES WITH IMPROVED CARRIER MOBILITY - A method of fabricating a multi-gate device is disclosed. In one aspect, the method includes providing a substrate having a first semiconductor layer with a first carrier mobility enhancing parameter, an insulating layer, a second semiconductor layer with a second carrier mobility enhancing parameter different from the first carrier mobility enhancing parameter. A first and second dielectric layer are then provided on the substrate. A first trench is formed in a first active region through the dielectric layers, the second semiconductor layer and the buried insulating layer. A first fin is formed in the first trench, protruding above the first dielectric layer and having the first carrier mobility enhancing parameter. A second trench is formed in a second active region through the dielectric layers. A second fin is formed in the second trench, protruding above the first dielectric layer and having the second mobility enhancing parameter. | 06-25-2009 |
20110068375 | MULTI-GATE SEMICONDUCTOR DEVICES WITH IMPROVED CARRIER MOBILITY - A multi-gate device is disclosed. In one aspect, the device includes a substrate having a first semiconductor layer of a first carrier mobility enhancing parameter, a buried insulating layer, and a second semiconductor layer with a second carrier mobility enhancing parameter. The device also includes a first active region electrically isolated from a second active region in the substrate. The first active region has a first fin grown on the first semiconductor layer and having the first mobility enhancing parameter. The second active region has a second fin grown on the second semiconductor layer and having the second mobility enhancing parameter. The device also includes a dielectric layer over the second semiconductor layer which is located between the first fin and the second fin. The first and second fins protrude through and above the dielectric layer. | 03-24-2011 |
20110317486 | Methods for Operating a Semiconductor Device - Multi-gate metal-oxide-semiconductor (MOS) transistors and methods of operating such multi-gate MOS transistors are disclosed. In one embodiment, the multi-gate MOS transistor comprises a first gate associated with a first body factor and comprising a first gate electrode for applying a first gate voltage, and a second gate associated with a second body factor greater than or equal to the first body factor and comprising a second gate electrode for applying a second gate voltage. The multi-gate MOS transistor further comprises a body of semiconductor material between the first dielectric layer and the second dielectric layer, where the semiconductor body comprises a first channel region located close to the first dielectric layer and a second channel region located close to the second dielectric layer. The multi-gate MOS transistor still further comprises a source region and a drain region each having a conductivity type different from a conductivity type of the body. | 12-29-2011 |
20130341185 | Micro-Stimulation and Data Acquisition From Biological Cells - The present invention relates to a method for fabricating a semiconductor device for stimulation and/or data recording of biological material to a such semiconductor device. The method comprises providing a semiconductor substrate comprising a first insulating layer; providing a patterned conductive layer on top of the first insulating layer; depositing and patterning a second insulating layer atop the patterned conductive layer; growing carbon nano-sheets atop the second insulating layer; and defining carbon nano-sheet electrode areas on the second insulating layer by etching away the carbon nano-sheets outside of the carbon nano-sheet electrode areas. | 12-26-2013 |
Nadine Davey-Rogers, Plantation, FL US
Patent application number | Description | Published |
---|---|---|
20130073340 | SYSTEMS AND METHODS FOR GENERATING BUSINESS INSIGHTS - A system for generating business insights is disclosed. The method may comprise analyzing internal data based upon a merchant request, generating a business insight based upon the analysis of the internal data and the merchant request, wherein the business insight is in a category of at least one of: customer intelligence, competitive intelligence, and market intelligence, and transmitting the business insight to a merchant associated with the merchant request. Customer intelligence may comprise information about a customer's spending behavior, demographics, and lifestyle characteristics. Likewise, competitive intelligence may comprise information about the competitive performance of the merchant, customer loyalty trends associated with the merchant, and market share of the merchant, and market intelligence may comprise market demographics, growth drivers, and industry-wide trends. Internal data may comprise data a credit issuer possesses pertaining to a particular consumer. | 03-21-2013 |
Nadine Dejneka, Wynnewood, PA US
Patent application number | Description | Published |
---|---|---|
20100151007 | COMPOSITIONS AND METHODS FOR SELECTIVE INHIBITION OF VEGF - Disclosed herein are siRNA compositions and methods useful for inhibiting expression of vascular endothelial growth factor (VEGF) isoforms. Such compositions and methods further involve siRNA capable of selectively targeting angiogenic VEGF isoforms while selectively sparing anti-angiogenic isoforms. Diseases which involve angiogenesis stimulated by overexpression of VEGF, such as diabetic retinopathy, age related macular degeneration and many types of cancer, can be treated by administering small interfering RNAs as disclosed. | 06-17-2010 |
20110142915 | COMPOSITIONS AND METHODS FOR INHIBITION OF VEGF - Disclosed herein are siRNA compositions and methods useful for inhibiting expression of vascular endothelial growth factor (VEGF) isoforms. Diseases which involve angiogenesis stimulated by overexpression of VEGF, such as diabetic retinopathy, age related macular degeneration and many types of cancer, can be treated by administering small interfering RNAs as disclosed. | 06-16-2011 |
20130039971 | COMPOSITIONS AND METHODS FOR INHIBITION OF VEGF - Disclosed herein are siRNA compositions and methods useful for inhibiting expression of vascular endothelial growth factor (VEGF) isoforms. Diseases which involve angiogenesis stimulated by overexpression of VEGF, such as diabetic retinopathy, age related macular degeneration and many types of cancer, can be treated by administering small interfering RNAs as disclosed. | 02-14-2013 |
Nadine Ding, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20140336747 | BIORESORBABLE IMPLANTS FOR TRANSMYOCARDIAL REVASCULARIZATION - Implants for treating insufficient blood flow to a heart muscle with transmyocardial revascularization are disclosed. Methods of treating insufficient blood flow to a heart muscle with the implant are also disclosed. The implant can have a body with an inner lumen that supports a channel in the heart muscle to allow for increased blood flow through the lumen upon implantation. The implant can include active agents to prevent or inhibit thrombotic closure of the channel, to promote vascularization, or both. | 11-13-2014 |
Nadine Dyrla, Bouc Bel Air FR
Patent application number | Description | Published |
---|---|---|
20130184958 | METHOD OF CONTROLLING A GROUP OF ENGINES, AND AN AIRCRAFT - A method of controlling a group ( | 07-18-2013 |
20130264412 | ROTARY WING AIRCRAFT HAVING A TAIL ROTOR, AND A METHOD OF OPTIMIZING THE OPERATION OF A TAIL ROTOR - A rotary wing aircraft ( | 10-10-2013 |
20140117148 | METHOD OF MANAGING AN ENGINE FAILURE ON A MULTI-ENGINED AIRCRAFT HAVING A HYBRID POWER PLANT - A method of managing an engine failure on a rotary wing aircraft ( | 05-01-2014 |
Nadine Eisele, Kufstein AT
Patent application number | Description | Published |
---|---|---|
20130209608 | ASPARAGINASE FROM BASIDIOMYCETES - An asparaginase enzyme derived from the fungi Basidiomycete, in particular the Basidiomycete is | 08-15-2013 |
20150093472 | ASPARAGINASE FROM BASIDIOMYCETES - An asparaginase enzyme derived from the fungi Basidiomycete, in particular the Basidiomycete is | 04-02-2015 |
Nadine Ellison-Marion, West Henrietta, NY US
Patent application number | Description | Published |
---|---|---|
20150109609 | OBJECT LOCATION IN THREE DIMENSIONAL SPACE USING LED LIGHTS - A system and method of for performing an action at a device is disclosed. A first signal is sent into a first zone from a first light source, wherein the first signal identifies the first zone. The first signal is received at the device when the device is in the zone. The device determines from the received first signal that the device is in the first zone and performs the action at the device based on the device being in the first zone. A second variable light source may send a second signal into a second zone, wherein the second signal identifies the second zone. Triangulation may be performed to determine a location of the device using the first signal and the second signal. Alternately, a parameter of motion of the device may be determined using the received messages. | 04-23-2015 |
20150109612 | OBJECT LOCATION IN THREE DIMENSIONAL SPACE USING LED LIGHTS - A method for performing an action at a device is disclosed. A first signal is sent into a first zone from a first light source, wherein the first signal identifies the first zone. The first signal is received at the device when the device is in the zone. The device determines from the received first signal that the device is in the first zone and performs the action at the device based on the device being in the first zone. A second variable light source may send a second signal into a second zone, wherein the second signal identifies the second zone. Triangulation may be performed to determine a location of the device using the first signal and the second signal. Alternately, a parameter of motion of the device may be determined using the received messages. | 04-23-2015 |
Nadine Essayem, Saint Just Chaleyssin FR
Patent application number | Description | Published |
---|---|---|
20110146137 | Method for Preparing a Mixture of Biofuels - The invention relates to a method of preparing a mixture of biofuels comprising fatty acid esters and at least one mixture of glycerol ethers from fatty substances that may contain free fatty acids and ethanol comprising: a) a step of transesterification of a vegetable or animal oil by ethanol in the presence of a catalyst based on at least one alkali metal salt or ammonium heteropolyacid salt characterized by differential heat of absorption of ammonia which is greater than or equal to 150 kJ/mol, stable at T>150° C., in order to obtain fatty acid esters and glycerol, and, b) a step of etherification of the glycerol formed during step a) by the alcohol used in step a) in the presence of the catalyst from step a) in order to obtain at least one ether of the glycerol, said steps a) and b) taking place simultaneously, in one and the same reactor. | 06-23-2011 |
20130053601 | PROCESS FOR TRANSFORMATION OF LIGNOCELLULOSIC BIOMASS OR CELLULOSE BY TUNGSTEN-BASED SOLID LEWIS ACIDS - The invention relates to a process for transformation of lignocellulosic biomass or cellulose that uses tungsten-based heterogeneous catalysts that are dispersed on an oxide-based substrate, preferably with a base of oxide(s) of aluminum and/or zirconium and/or titanium and/or niobium. The use of these catalysts makes it possible to obtain directly lactic acid with high selectivity while limiting the production of oligosaccharides and soluble polymers. | 02-28-2013 |
20130105738 | METHOD FOR OBTAINING COMPOSITIONS OF BIOSOLVENTS BY ESTERIFICATION AND OBTAINED COMPOSITIONS OF BIOSOLVENTS | 05-02-2013 |
20130184496 | PROCESS FOR TRANSFORMATION OF LIGNOCELLULOSIC BIOMASS OR CELLULOSE BY TUNGSTEN-OXIDE-BASED SOLID LEWIS ACID CATALYSTS AND A METAL THAT IS SELECTED FROM GROUPS 8 TO 11 - The invention relates to a process for transformation of lignoceliulosic biomass or cellulose that uses tungsten-oxide-based heterogeneous catalysts that are dispersed on an oxide-based substrate, preferably with a base of oxide(s) of aluminum and/or zirconium and/or titanium and/or niobium and containing an element in the particular metallic state. The use of these catalysts makes it possible to obtain directly upgradable products containing three carbon atoms, in particular hydroxyacetone and propylene glycol with high selectivity. | 07-18-2013 |
20130281734 | PROCESS FOR CONVERTING CELLULOSE OR LIGNOCELLULOSIC BIOMASS USING STABLE NON-ZEOLITE SOLID LEWIS ACIDS BASED ON TIN OR ANTIMONY ALONE OR AS A MIXTURE - The invention relates to a process for transformation of lignocellulosic biomass or cellulose using stable non-zeolitic heterogeneous catalysts that are based on tin and/or antimony, preferably dispersed on a substrate. The use of these catalysts makes it possible to obtain directly lactic acid with high selectivity while limiting the production of oligosaccharides and soluble polymers. | 10-24-2013 |
20130281741 | PROCESS FOR TRANSFORMATION OF LIGNOCELLULOSIC BIOMASS OR CELLULOSE BY CATALYSTS BASED ON TIN OXIDE AND/OR ANTIMONY OXIDE AND A METAL THAT IS SELECTED FROM THE GROUPS 8 TO 11 - The invention relates to a process for transformation of lignocellulosic biomass or cellulose using heterogeneous catalysts that are based on tin oxide and/or antimony oxide, dispersed on a substrate and containing at least one element in the particular metal state. The use of these catalysts makes it possible to obtain directly upgradable products, in particular hydroxyacetone and propylene glycol with high selectivity. | 10-24-2013 |
20140121389 | Method for Producing 5-Hydroxymethylfurfural - The invention relates to a method for preparing 5-hydroxymethylfurfural (HMF) by reacting hexose in water and in the presence of carboxylic acid. The present invention further relates to the preparation of 5-hydroxymethylfurfural (HMF) by reacting hexose in water and in the presence of carboxylic acid and of a heterogenous acid catalyst. The invention also relates to an HMF-rich carboxylic acid solution. | 05-01-2014 |
20140309440 | Method for Preparing Furfural - The invention relates to a method for preparing furfural by reacting pentose in water and in the presence of carboxylic acid and of a heterogeneous acid catalyst, the method being conducted in an aqueous solution of carboxylic acid as a reaction medium. The present invention also relates to the preparation of furfural by reaction of pentose in water and in the presence of carboxylic acid and of a heterogeneous acid catalyst. The invention also relates to an aqueous solution of carboxylic acid rich in furfural. | 10-16-2014 |
20150126731 | Method for the Isomerisation of Glucose into Fructose - The invention relates to a method for the isomerisation of glucose into fructose in water in the presence of a solid base catalyst characterised by its reversibility of CO | 05-07-2015 |
Nadine Ferriss, Ottawa CA
Patent application number | Description | Published |
---|---|---|
20080248936 | Therapeutic Neutral Spine and Exercise Device and Method of Applying Same - An “I” shaped therapeutic neutral spine and exercise device for improving muscle balance and soft-tissue and dural/nerve mobility by encouraging and facilitating proper neutral position of the entire spine is disclosed. The device has three sections of different dimensions; a cervical, thoracic and lumbar section. Each section is placed at a specific area of the spine. Each section can be utilized independently or as a whole by health care providers while administering manual therapy techniques or by users themselves by self-administering stretches. Each section is filled with grain, bean, pea, shell or synthetic substance with optionally attachable tabs to allow the user to utilize each section independently or the device as a whole. The device comes in various sizes to accommodate various lengths of the spine. Methods of administering the therapeutic neutral spine and exercise device on users by health care professionals for enhancing neutral spinal position, improving muscle balance, soft tissue and nerve tissue tension are also disclosed. | 10-09-2008 |
Nadine Gergel-Hackett, Germantown, MD US
Patent application number | Description | Published |
---|---|---|
20090184397 | NONVOLATILE MEMORY DEVICE AND PROCESSING METHOD - A method of processing a nonvolatile memory device includes forming a first electrode, depositing a layer of sol-gel solution on the first electrode, hydrolyzing the layer of sol-gel solution to form a layer of variable electric resistance material, and forming a second electrode on the layer of variable electric resistance material. | 07-23-2009 |
Nadine Gervois, Nantes FR
Patent application number | Description | Published |
---|---|---|
20090081226 | Soluble HLA-E Molecules And Their Use For Diagnosing And Treating Pathologies - The present invention relates to a purified soluble HLA-E molecule, characterized in that: | 03-26-2009 |
Nadine Goetz, Villeneuve Le Roi FR
Patent application number | Description | Published |
---|---|---|
20100183535 | PROCESS OF MANUFACTURING A SOLID COSMETIC PRODUCT - A process of manufacturing a solid cosmetic product, includes the steps of applying to a composition based on powder and fluid binder, introduced into a mould, a sheet of porous material having an average pore diameter ranging from 5 to 180 μm; then passing at least some of the volatile solvent through the sheet; removing the volatile solvent that has passed through the sheet and drying the composition in order to solidify it before depositing it in a packaging. The solid product obtained according to this process and to its uses as a face and/or body makeup product are also described. | 07-22-2010 |
Nadine Goubot, Pont Saint Esprit FR
Patent application number | Description | Published |
---|---|---|
20110097504 | Method for the Anti-Corrosion Processing of a Part by Deposition of a Zirconium and/or Zirconium Alloy Layer - The invention relates to a method for the anti-corrosion processing of a part that comprises the step of spray deposition of a zirconium and/or zirconium alloy layer onto the surface thereof. | 04-28-2011 |
Nadine Hollfelder, Rutesheim DE
Patent application number | Description | Published |
---|---|---|
20110240917 | BLUE PHASE LIQUID CRYSTAL COMPOSITION - The present invention relates to a blue phase (BP) liquid crystal composition and to a method of stabilizing a blue phase state of a liquid crystal material. Furthermore, the present invention relates to a method of lowering the operating voltage of a liquid crystal material. Moreover, the present invention relates to a blue phase crystal material stabilized by the method according to the present invention or having an operating voltage that is lowered by the method according to the present invention. Also, the present invention relates to a liquid crystal cell comprising a blue phase liquid crystal material and to a liquid crystal display comprising a blue phase liquid crystal material. The present invention furthermore relates to a method of broadening that stability temperature range of a liquid crystal material in its blue phase state. | 10-06-2011 |
20110240920 | BLUE PHASE LIQUID CRYSTAL COMPOSITION - The present invention relates to a blue phase liquid crystal composition and to a method of stabilizing a blue phase state of a liquid crystal material. Moreover, the present invention also relates to a method of lowering the operating voltage of a liquid crystal material. Furthermore, the present invention relates to a blue phase liquid crystal material stabilized by the method according to the present invention or having an operating voltage that is lowered by the method according to the present invention. Furthermore, the present invention relates to a liquid crystal cell comprising a blue phase liquid crystal material and to a liquid crystal display comprising a blue phase liquid crystal material. The present invention also relates to a method of broadening the stability temperature range of a liquid crystal material in its blue phase state. | 10-06-2011 |
20130070193 | METHOD OF STABILIZING A BLUE PHASE LIQUID CRYSTAL COMPOSITION - The present invention relates to a method of stabilizing a blue phase liquid crystal composition. The present invention also relates to a method of producing a liquid crystal cell or display. Moreover, the present invention relates to a stabilized blue phase liquid crystal composition and to a liquid crystal cell or display prepared in accordance with the present invention. Moreover, the present invention relates to an electronic device comprising a stabilized liquid crystal composition. | 03-21-2013 |
Nadine Hosele, Vienna AT
Patent application number | Description | Published |
---|---|---|
20110248034 | FOIL-LID TO CLOSE A TRAY, AND METHOD OF MANUFACTURING SAID FOIL-LID - Foil lid for closing a container, wherein the foil lid comprises composite layers, wherein the composite layers comprise a first layer group and a second layer group, wherein both the first layer group and the second layer group comprise at least one layer of a first type and one layer of a second type, and the layer of the first type of the first layer group is blocked over its entire area with the layer of the first type of the second layer group, and wherein at least the first layer group, which faces the container when the foil lid is used as intended, comprises a zone of weakness which defines the periphery of an opening. | 10-13-2011 |
Nadine Iroff, Perkiomenville, PA US
Patent application number | Description | Published |
---|---|---|
20090048406 | PROCESS FOR PREPARING CONTINUOUSLY VARIABLE-COMPOSITION COPOLYMERS - A continuously variable composition copolymer is prepared in a reaction system, by (a) providing a reaction vessel comprising a first monomer composition; (b) providing a feed vessel comprising a second monomer composition; (c) initiating a polymerization reaction in the reaction vessel; (d) continuing the polymerization reaction during the gradual addition of the second monomer composition from the feed vessel to the reaction vessel, wherein the gradual addition of the second monomer composition is performed such that the continuously variable composition copolymer is obtained; (e) maintaining the polymerization until at least 90% of the total monomer composition has been converted to the copolymer; wherein the copolymer has a weight average molecular weight from 10,000 to 1,000,000; wherein the copolymer is soluble in lubricating oil, wherein the monomers of the first monomer composition provided in the reaction vessel comprise at least 50% by weight of all the monomers used to prepare the copolymer. | 02-19-2009 |
20140206823 | METHOD FOR REDUCING THE HALOGEN CONTENT OF A POLYMER - The invention relates to a method for reducing the halogen content of a polymer, characterized in that the polymer is reacted with a polymerization inhibitor; and especially to a method wherein said polymer is a polymerization product of an ATRP process. | 07-24-2014 |
Nadine Ismiel-Nash, Kenthurst AU
Patent application number | Description | Published |
---|---|---|
20150080910 | WAX APPLICATOR - A wax applicator is provided for applying epilation wax to nasal cavities, comprising a stem for handling the wax applicator, a nipple at one end of the stem, and a collar disposed around the stem at a base of the nipple, wherein the nipple has a contoured surface that narrows at its base where it meets the collar, operatively to achieve formlock with hardened epilation wax following cooling of hot epilation wax applied to the nipple, and thereby allowing removal from their roots of hairs set in the hardened epilation wax. | 03-19-2015 |
Nadine Jagerovic, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100004224 | 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS - The invention relates to the use of compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,4-triazole derivatives of formula (I) to processes of preparation of such compounds and to pharmaceutical compositions comprising them. | 01-07-2010 |
20100004265 | 1,2,3-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS - The invention relates to compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,3-triazole derivatives of formula (I) and to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy and prophylaxis, in particular for the treatment of psychosis or pain. | 01-07-2010 |
20120004211 | 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS - The invention relates to the use of compounds having pharmacological activity towards the sigma receptor, and more particularly to 1,2,4-triazole derivatives of formula I | 01-05-2012 |
Nadine Jung, Muenchen DE
Patent application number | Description | Published |
---|---|---|
20100296055 | METHOD FOR DETERMINING FAR AND NEAR REFERENCE POINTS - The invention relates to a method for specifying or determining the spatial position of a distance reference point and/or a near reference point of a progressive spectacle lens for correcting defective vision of a spectacle wearer. Said method consists of the following steps: individual data of the spectacle wearer is obtained; the individual vertical and/or the horizontal position of the distance reference point and/or the near reference point is determined or calculated in accordance with the determined individual data of the spectacle wearer. | 11-25-2010 |
20120008090 | CONTROLLING DESIGNS USING A POLYGONAL DESIGN - A method and device for calculating design parameters of a design of a progressive spectacle lens on the basis of a predetermined design polygon. The design parameters are calculated by specifying a point within the design polygon, in which the specified point defines the progressive spectacle lens design, and then determining a value of each design parameter at the specified point by an interpolation of at least part of the predetermined values at the corner points and, optionally, of at least part of the predetermined values of the design parameter at the at least one additional point. | 01-12-2012 |
Nadine Koch, Cologne DE
Patent application number | Description | Published |
---|---|---|
20110300263 | POLYPEPTIDES HAVING CELLOBIOHYDROLASE II ACTIVITY - Provided herein are improved variants of polypeptides having cellobiohydrolase II activity, nucleic acids encoding the polypeptides, vectors, host cells containing the nucleic acids and methods for producing the polypeptides. The polypeptides encompassed by this disclosure may be used in numerous applications including the use of the polypeptides for the production of biofuels and for the synthesis of platform chemicals or biopolymers from renewable sources. | 12-08-2011 |
Nadine Konisch, Edemissen DE
Patent application number | Description | Published |
---|---|---|
20150104830 | AVIAN CELL LINE AND ITS USE IN PRODUCTION OF PROTEIN - The invention provides a process for generating an avian cell line of duck origin by a process comprising: —cultivating embryonic avian cells in cell culture medium, preferably comprising fetal calf serum (FBS) for more than 40 passages while reducing the concentration of FBS to 1-2% vol/vol FBS, —transferring passaged cells into cell culture medium having 0% FBS, —resulting in the generation of a non-embryonic avian cell line suitable for non-adherent growth, i.e. for growth in suspended culture. | 04-16-2015 |
Nadine Laguette, Saint Georges D'Orgues FR
Patent application number | Description | Published |
---|---|---|
20140010839 | METHOD OF SCREENING ANTIRETROVIRAL COMPOUNDS AND VACCINE - The present invention relates to an in vitro method of screening for candidate compounds capable of being used for the preventative and/or curative treatment of a disease caused by a retrovirus in which the candidate compound which modulates the expression and/or the activity of the SAMHD1 protein is identified as a candidate compound capable of being used for the preventative and/or curative treatment of a disease caused by a retrovirus. | 01-09-2014 |
Nadine Langenscheidt, Aachen DE
Patent application number | Description | Published |
---|---|---|
20110021798 | Ruthenium Complexes with (P-P)-Coordinated Ferrocenyldiphosphine Ligands, Process for Preparing Them and Their Use in Homogeneous Catalysis - The invention relates to ruthenium complexes with a chiral ferrocenyldiphosphine ligand, wherein the ruthenium has the oxidation state (+II) and the chiral ferrocenyldiphosphine ligand has bidentate P—P coordination to the ruthenium. The ruthenium complexes are cyclic and with the ferrocenyldiphosphine ligand have an at least eight-membered ring. The ferrocenyldiphosphine ligands are selected from the group consisting of Taniaphos, Taniaphos-OH and Walphos ligands. A process for preparing the Ru complexes is described. The Rn complexes are used as catalysts for homogeneous asymmetric catalysis for preparing organic compounds. | 01-27-2011 |
Nadine Langenscheidt-Dabringhausen, Baesweiler DE
Patent application number | Description | Published |
---|---|---|
20140235524 | STRUCTURED DETERGENT OR CLEANING AGENT HAVING A FLOW LIMIT II - The invention describes a stable liquid washing agent or liquid cleaning agent having a yield point and very good dispersing properties. The agents contain anionic and nonionic surfactants as well as inorganic salt and cosurfactant. The invention also relates to the use of the liquid washing agent or liquid cleaning agent, and to a method for manufacturing it. | 08-21-2014 |
20140243253 | STRUCTURED DETERGENT OR CLEANING AGENT HAVING A FLOW LIMIT - The invention describes a stable liquid washing agent or liquid cleaning agent having a yield point and very good dispersing properties. The agents contain anionic and nonionic surfactants as well as inorganic salt, at a specific ratio to one another. The invention also relates to use of the liquid washing agent or liquid cleaning agent, and to a method for manufacturing it. | 08-28-2014 |
Nadine Licau, Les Ulis FR
Patent application number | Description | Published |
---|---|---|
20090238921 | MUTANT STRAINS OF LACTIC ACID BACTERIA HAVING A NON-PHOSPHORYLABLE LACTOSE PERMEASE - The invention concerns lactic acid bacteria strains wherein the phosphorylable histidine of the IIA domain of lactose permease is replaced by a non-phosphorylable amino acid. Said strains have a reduced post-acidification and are useful in particular for preparing fermented dairy products. | 09-24-2009 |
Nadine Liebs, Erlangen DE
Patent application number | Description | Published |
---|---|---|
20130035957 | METHOD AND ARRANGEMENT FOR COMPUTER-ASSISTED REPRESENTATION AND/OR EVALUATION OF MEDICAL EXAMINATION DATA - Computer-assisted structuring of medical examination data and/or one or more examination data records is disclosed. A method of at least one embodiment includes providing at least one medical examination data record, which includes patient-specific data described textually and/or symbolically and/or at least one image data record created with the aid of a radiological examination device; providing at least one body model image, which represents a body model matching the examination data; and registering the at least one examination data record with the body model, wherein at least one position in the body model is assigned to the examination data record; the position being made known for interaction by way of a user interface. | 02-07-2013 |
Nadine Losleben, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20150041375 | MICRO FLOW FILTRATION SYSTEM AND INTEGRATED MICROFLUIDIC ELEMENT - A micro fluid filtration system ( | 02-12-2015 |
20150041395 | MICRO FLOW FILTRATION SYSTEM AND FLOW FILTRATION METHOD - A micro flow filtration system comprises a fluid circuitry ( | 02-12-2015 |
20150048119 | MICROFLUIDIC DISPENSER, CARTRIDGE AND ANALYSIS SYSTEM FOR ANALYZING A BIOLOGICAL SAMPLE - A dispenser for dispensing a fluid is presented. The dispenser comprises a compressible elastomeric fluid conduit having a first end and a second end for flowing the fluid from the first end to the second end, a first check valve and a second check valve distanced in the conduit for forming a fluid chamber, and an actor for compressing the fluid chamber for dispensing a portion of the fluid. At least the second check valve is a duckbill valve. The second check valve is located at the second end of the conduit. The second check valve has sealing lips that extend beyond the second end of the conduit. | 02-19-2015 |
20150050719 | DISPENSING ASSEMBLY - A dispensing assembly comprising a cartridge holder is presented. The cartridge holder can receive a cartridge for dispensing a fluid. The cartridge can comprise a reservoir for receiving the fluid. The reservoir can comprise an outlet. The reservoir can have an adjustable volume for forcing the fluid through the outlet. The cartridge can further comprise a nozzle for dispensing the fluid. The nozzle can be connected to the outlet. The dispensing assembly can further comprise an actuator for actuating the adjustable volume. The dispensing assembly can further comprise an impulse generator for imparting an impulse to the nozzle. The impulse generator can comprise an actor for contacting the nozzle. The dispenser assembly can further comprise a controller for controlling the actor and the impulse generator. | 02-19-2015 |
20150083665 | MICRO FLOW FILTRATION SYSTEM AND FLOW FILTRATION METHOD FOR A FLUID SAMPLE - A flow filtration system ( | 03-26-2015 |
Nadine Loubere, Pardies FR
Patent application number | Description | Published |
---|---|---|
20110033943 | HYDROGEN SULPHIDE SAMPLING METHOD - The invention relates to a method for sampling a sulphur-containing solid product including supplying a gas flow comprising hydrogen sulphide, bringing the gas flow into contact with a solid reagent and reacting the solid reagent with the hydrogen sulphide contained in the gas flow, the reaction fixing the sulphur of the hydrogen sulphide by forming a sulphur-containing solid product which is different in colour from the solid reagent, and recovering the sulphur-containing solid product. The invention also relates to a device suitable for the implementation of this method. | 02-10-2011 |
20140017144 | HYDROGEN SULPHIDE SAMPLING METHOD - A method for sampling a sulphur-containing solid product including supplying a gas flow comprising hydrogen sulphide, bringing the gas flow into contact with a solid reagent and reacting the solid reagent with the hydrogen sulphide contained in the gas flow, the reaction fixing the sulphur of the hydrogen sulphide by forming a sulphur-containing solid product which is different in colour from the solid reagent, and recovering the sulphur-containing solid product. The invention also relates to a device suitable for the implementation of this method. | 01-16-2014 |
Nadine Malhouroux Gaffet, Evette-Salbert FR
Patent application number | Description | Published |
---|---|---|
20130289877 | GUIDANCE BY RADIO FOCUSING - A method of guidance by radio focusing includes a “visitor” entity heading towards a radio source of number k=1 (or k=k | 10-31-2013 |
Nadine Martin, Champ Sur Drac FR
Patent application number | Description | Published |
---|---|---|
20150115424 | ELECTRONIC SYSTEM COMPRISING STACKED ELECTRONIC DEVICES PROVIDED WITH INTEGRATED-CIRCUIT CHIPS - An electronic system includes a first electronic device (with a first integrated-circuit chip) and a second electronic device (with a second integrated-circuit chip). The second electronic device is stacked above the first electronic device on a same side as the first integrated-circuit chip. Electrical connection elements located around the first integrated-circuit chip electrically connected to the second electronic device to the first electronic device. A metal plate configured for heat capture and transfer extends between the first and second electronic devices. The metal plate includes through-passages aligned to permit the electrical connection elements to pass at a distance. | 04-30-2015 |
Nadine Moellers, Berlin DE
Patent application number | Description | Published |
---|---|---|
20140102929 | RECEPTACLE FOR AUTOGRAPH CARDS - A receptacle for autograph cards, characterized in that it is formed from a container with a wide compartment for the autograph cards, with a narrow compartment for a writing device arranged next to it, and is formed with a cover flap which may be flapped over the compartments. | 04-17-2014 |
Nadine Mothes-Luksch, Vienna AT
Patent application number | Description | Published |
---|---|---|
20080261215 | Method for Evaluating the Allergen Sensitivity of an Individual - The present invention discloses a method for evaluating the allergen sensitivity of an individual and/or the clinical efficacy of an allergen immunotherapy comprising the steps: providing at least two samples selected from the group consisting of blood or fractions thereof, connective tissue, nasal, bronchial, skin or gut biopsy material from an individual subjected or intended to be subjected to an immunotherapy with at least one pure allergen or derivative thereof, wherein the samples contain cells capable of releasing mediators in response to said allergen, contacting said sample with said allergen or derivative thereof, and determining the amounts of mediators released from said sample and evaluating the allergen sensitivity of the individual prior to therapy and/or the clinical efficacy of the immunotherapy by comparing said amounts. | 10-23-2008 |
Nadine Niebur, Munster DE
Patent application number | Description | Published |
---|---|---|
20080261290 | Tetrahymena Heat Inducible Promoters and Their Use - The present invention relates to heat-inducible promoters of the heat shock protein family of the ciliate | 10-23-2008 |
Nadine Offermans-Knooren, Ubachsberg NL
Patent application number | Description | Published |
---|---|---|
20080224969 | Increase of Perceived Resolution for a Dual View Display Device - A representative display device for displaying a first and a second view (V | 09-18-2008 |
Nadine Paiement, Ville St. Laurent CA
Patent application number | Description | Published |
---|---|---|
20110136815 | SOLID ORAL FILM DOSAGE FORMS AND METHODS FOR MAKING SAME - Improved pharmaceutical solid oral film dosage forms for the buccal and/or sublingual delivery of pharmaceutical, nutraceutical or cosmetic ingredients are endowed with instant hydration potential and complete dissolution potentially enabling the active ingredient to become immediately available for enhanced buccal and/or sublingual absorption and/or reduced absorption through the gastrointestinal route. The improved delivery systems for solubilizing and stabilizing pharmaceutically active ingredients exhibit enhanced stability by the use of a combination of crystallization inhibitors, which together can maintain the active ingredient in a desired plurality of particles in an effective size range within a polymeric film matrix. | 06-09-2011 |
20110263606 | SOLID ORAL DOSAGE FORMS COMPRISING TADALAFIL - Improved pharmaceutical solid oral dosage forms for the buccal and/or sublingual delivery of Tadalafil. The improved delivery systems for solubilizing and stabilizing pharmaceutically active ingredients exhibit enhanced methods of preparation by the use improved solubilization systems which can maintain the Tadalafil in a buccal and/or sublingual oral dosage form or a polymeric film matrix that provides improved bioavailability and/or absorption of Tadalafil. | 10-27-2011 |
20130137698 | SOLID ORAL FILM DOSAGE FORMS AND METHODS FOR MAKING SAME - Improved pharmaceutical solid oral film dosage forms for the buccal and/or sublingual delivery of pharmaceutical, nutraceutical or cosmetic ingredients are endowed with instant hydration potential and complete dissolution potentially enabling the active ingredient to become immediately available for enhanced buccal and/or sublingual absorption and/or reduced absorption through the gastrointestinal route. The improved delivery systems for solubilizing and stabilizing pharmaceutically active ingredients exhibit enhanced stability by the use of a combination of crystallization inhibitors, which together can maintain the active ingredient in a desired plurality of particles in an effective size range within a polymeric film matrix. | 05-30-2013 |
Nadine Perschmann, Lauffen DE
Patent application number | Description | Published |
---|---|---|
20110275539 | SUBSTRATE FOR SELECTING AND SPECIFICALLY INFLUENCING THE FUNCTION OF CELLS - The invention relates to a method and to a substrate for selecting and specifically influencing the function of cells by the adhesion thereof to substrate surfaces having prescribed properties. Said substrates comprise various surface regions each representing a condition affecting the cell adhesion and/or cell function, and said conditions are determined by a geometric property and/or a mechanical property or a combination of a geometric property and/or a mechanical property with a chemical property of each surface region. The invention further relates to analysis devices and to analysis methods using said substrates for identifying and selecting particular cell types, for identifying suitable substrate conditions for affecting a particular cell function or particular cell type or for identifying disease states characterized by a change in the cell type or cell function. | 11-10-2011 |
Nadine Poupa-Parsigneau, Dordives FR
Patent application number | Description | Published |
---|---|---|
20130062130 | Electric or Hybrid Motor Vehicle Bodywork Structure, This Vehicle, and Method for Controlling/Modifying the Temperature of the Passenger Compartment Thereof - A bodywork structure for controlling or modifying the temperature of a passenger compartment of an electric or hybrid motor vehicle is provided. The bodywork structure includes at least one interior and exterior panel and one intermediate layer between the panels, each panel being based on a thermally conducting and electrically insulating material. The intermediate layer has at least one phase change material PCM and electric components coupled to it and is configured to be connected to an accumulator battery and which are able to convert the electrical energy available when the battery is being recharged into thermal energy stored by the PCM, so that the stored thermal energy is then transmitted to the interior of the vehicle when the latter is in use thanks to crystallizing of the at least one PCM, which is conversely able, by melting, to absorb an excess of heat inside the vehicle when this PCM is not recharged. | 03-14-2013 |
Nadine Questiaux, Louvain-La-Neuve BE
Patent application number | Description | Published |
---|---|---|
20110111423 | Demethylated and / or oxidized membrane DNA - A process for the preparation of oxidized and/or demethylated antigens comprising the steps of | 05-12-2011 |
Nadine Riediger, Schifferstadt DE
Patent application number | Description | Published |
---|---|---|
20140193472 | Formulations for paddy rice fields - The present invention relates to microcapsules, formulations comprising such microcapsules and to methods of combating phytopathogenic pests in paddy rice fields based on such microcapsules. | 07-10-2014 |
20140364317 | SOLID AGROFORMULATIONS PREPARED FROM A MELT OF PESTICIDE AND POLYALKOXYLATE, OPTIONALLY CONTAINING LIQUID ADJUVANT COMPLEXED WITH POLYCARBOXYLATE - The present invention relates to a method for a preparation of a solid composition comprising the steps of a) dissolving a premix in a premix-solvent, or melting a premix, wherein the premix contains a pesticide and a nonionic, amphiphilic polyalkoxylate, b) solidifying the premix by removing the premix-solvent, or by cooling, and c) contacting the premix with at least one auxiliary. The invention further relates to a solid composition obtainable by said method; to a method for the preparation of an aqueous tank mix, in which a pesticide is present as suspended particles having a particle size below 1.0 μm, comprising the step of mixing water and a solid composition obtainable by the said method; and to a method for controlling phytopathogenic fungi and/or undesired plant growth and/or undesired attack by insects or mites and/or for regulating the growth of plants, where a solid composition obtainable by said method is allowed to act on the particular pests, their habitat or the plants to be protected from the particular pest, the soil and/or on undesired plants and/or the useful plants and/or their habitat. | 12-11-2014 |
20140371075 | EMULSIFIABLE CONCENTRATE COMPRISING PESTICIDE, AMIDE, CARBONATE AND HYDROCARBON - Subject matter of the present invention is an emulsifiable concentrate comprising a water-insoluble pesticide, an amide of the formula (I) | 12-18-2014 |
20150056257 | EMULSIFIABLE GRANULE OBTAINABLE BY MIXING AN PESTICIDAL EMULSION WITH SOLID DISPERSANT AND EXTRUDING THE RESULTING PASTE - The present invention relates to a method for preparing an emulsifiable granule comprising the steps of a) emulsifying water with a solution of a pesticide in a water-insoluble solvent, b) contacting the emulsion resulting from step a) and a solid dispersant containing a water-soluble polycarboxylate and a water-soluble anionic surfactant, and c) extruding the paste resulting from step b). The invention further relates to emulsifiable granules containing a water-insoluble solvent, a pesticide, which is dissolved in the water-insoluble solvent, a water-soluble polycarboxylate, and a water-soluble anionic surfactant. | 02-26-2015 |
Nadine Roth, Winden DE
Patent application number | Description | Published |
---|---|---|
20150150160 | In Planta Recombination - The present invention relates to methods to modify at least one target locus in a plant cell, comprising, providing a plant cell with one or more target loci and one or more donor loci, followed by induction of homologous recombination between homologous regions of at least one target locus and at least one donor locus by at least one rare cleaving nuclease. The present invention related also to target loci, donor loci and nuclease loci used in these methods, and plant cells, plants and plant parts comprising these target loci, donor loci, nuclease loci and/or the recombined loci. | 05-28-2015 |
Nadine Scandinaro, Export, PA US
Patent application number | Description | Published |
---|---|---|
20140090649 | Respiratory Mask with Disposable Cloth Body - The invention is a frameless, disposable cloth body for use with a respiratory mask, such as for continuous positive airway pressure therapy for those having sleep apnea. The cloth body is inflatable and moisture-vapor breathable and has an inner side having a nasal interface portion disposed on it and an outer side, and also has a circular aperture formed in a central location on the body, sized to sealingly receive an air delivery arrangement. The cloth body also has a pair of wings on opposite sides with slits arranged at optimal angles for receiving headgear straps. | 04-03-2014 |
Nadine Schnelder, Hilden DE
Patent application number | Description | Published |
---|---|---|
20130164238 | COSMETIC AEROSOL SPRAY - A cosmetic product includes a water-in-oil emulsion containing: a) at least one cosmetic active ingredient, b) at least one water-in-oil emulsifier, c) at least one non-ionic polyalkylene glycol ether having a HLB value >7, d) at least one C | 06-27-2013 |
Nadine Schoenewald, Attendorn DE
Patent application number | Description | Published |
---|---|---|
20150132045 | MOTOR-VEHICLE CAST PART - The invention relates to a shaped part ( | 05-14-2015 |
Nadine Schracke, Hirschberg DE
Patent application number | Description | Published |
---|---|---|
20120045771 | METHOD FOR ANALYSIS OF NUCLEIC ACID POPULATIONS - The invention relates to a method for isolation of target molecules from a nucleic acid population. | 02-23-2012 |
20120071327 | INDEXING OF NUCLEIC ACID POPULATIONS - The invention relates to a method for acquisition of genetic information, in particular for personalized medicine. | 03-22-2012 |
Nadine Schuell, Rheine DE
Patent application number | Description | Published |
---|---|---|
20110140431 | WIND TURBINE FARM AND METHOD OF CONTROLLING AT LEAST ONE WIND TURBINE - A method of controlling a wind turbine that includes at least one rotor shaft and at least one blade operatively coupled to the rotor shaft includes measuring a first wind turbine operational condition that is representative of a blade deflection value and generating a first operational condition signal based on that first wind turbine operational condition. The wind turbine also includes a drive train including at least one rotor shaft and an electric generator. The method also includes measuring at least one second wind turbine operational condition and generating at least one second operational condition signal. The method further includes changing the blade deflection value by changing the second operational condition. | 06-16-2011 |
Nadine SchÜll, Rheine DE
Patent application number | Description | Published |
---|---|---|
20110135466 | SYSTEM AND METHOD FOR MONITORING AND CONTROLLING WIND TURBINE BLADE DEFLECTION - A system is disclosed for monitoring and controlling the deflection of turbine blades of a wind turbine. The system includes a passive position detecting apparatus and a controller. The passive position detecting apparatus may be configured to acquire and transmit data relating directly to a position of at least one of the turbine blades. The controller may be configured to receive the data from the passive position detecting apparatus and compare such data to a known position reference to determine turbine blade deflection. | 06-09-2011 |
Nadine Steinhanses, Lennestadt DE
Patent application number | Description | Published |
---|---|---|
20110132487 | Tubular Component - A tubular component with an end section has a profile, wherein the profile comprises a plurality of holding elements axially offset in longitudinal direction of the end section. The holding elements comprise at least one first azimuthal contour region and at least one second azimuthal contour region, wherein the outer contour of a holding element in the first contour region at least in sections is lowered or raised relative to the second contour region and wherein the first contour regions of at least two holding elements are offset relative to each other in azimuthal direction. | 06-09-2011 |
Nadine Ströter, Bochum DE
Patent application number | Description | Published |
---|---|---|
20110135567 | MICROPOROUS TECTOSILICATE AND METHOD FOR THE PRODUCTION THEREOF - The present invention relates to a tectosilicate having an X-ray diffraction pattern in which at least the following reflections occur: | 06-09-2011 |
Nadine Takahashi, Yamato JP
Patent application number | Description | Published |
---|---|---|
20110229757 | POWER STORAGE DEVICE - An object is to increase the amount of ions capable of entering and leaving a positive electrode active material in an ion battery so that the capacity of the battery is increased. When a solid solution including alkali metal oxide having electrical conductivity less than or equal to 10 | 09-22-2011 |
20110229764 | POWER STORAGE DEVICE AND MANUFACTURING METHOD THEREOF - A power storage device comprising a positive electrode which includes in a positive electrode active material layer, lithium iron phosphate particles whose surface is supported by a carbon material and whose half width of the X-ray diffraction peak is less than or equal to 0.17°, or greater than or equal to 0.13° and less than or equal to 0.165′ or whose particle size is greater than or equal to 20 nm and less than 50 nm or greater than or equal to 30 nm and less than 40 nm; or a method for manufacturing a power storage device comprising the steps of mixing the lithium iron phosphate particles, a conduction auxiliary agent, and a binder so as to be a paste, and applying the paste on a current collector, thereby manufacturing a positive electrode. | 09-22-2011 |
20110236752 | POWER STORAGE DEVICE - A power storage device includes a positive electrode including a positive electrode current collector and a positive electrode active material having an olivine structure which is represented by a structural formula LiFe | 09-29-2011 |
20110269023 | POWER STORAGE DEVICE - A power storage device including a positive electrode having a positive electrode active material and a positive electrode current collector; and a negative electrode which faces the positive electrode with an electrolyte provided between the negative electrode and the positive electrode is provided. The positive electrode active material includes a first region which includes a phosphate compound containing lithium and nickel; and a second region which covers the first region and includes a compound containing lithium and one or more of iron, manganese, and cobalt, but not containing nickel. Since the entire superficial portion of a particle of the positive electrode active material does not contain nickel, nickel is not in contact with an electrolyte solution; thus, generation of a catalyst effect of nickel can be suppressed, and a high discharge potential of nickel can be utilized. | 11-03-2011 |
20110294009 | POWER STORAGE DEVICE - An object is to provide a power storage device with high discharge capacity and high energy density. The power storage device includes a positive electrode in which a positive electrode active material is formed over a positive electrode current collector; and a negative electrode which faces the positive electrode with an electrolyte interposed therebetween. The positive electrode active material includes a film-form first region which includes a compound containing lithium and nickel; and a film-form second region which includes a compound containing lithium and one or more of iron, manganese, and cobalt, but not containing nickel. The first region is covered with the second region. Since a superficial portion of the positive electrode active material does not contain nickel, nickel is not in contact with an electrolyte solution; thus, generation of a catalyst effect of nickel can be suppressed, and a high discharge potential of nickel can be utilized. | 12-01-2011 |
Nadine Taudte, Halle/saale DE
Patent application number | Description | Published |
---|---|---|
20110212853 | NOVEL DIAGNOSTIC METHOD - A method of monitoring treatment of an inflammatory disease or an inflammatory associated disease with the use of the ratio of N-terminal pyroglutamate modified MCP-1 (MCP-1 N1pE):total concentration of MCP-1 within a biological sample as a biomarker, and a method for determining the proportion of N-terminal pyroglutamate modified MCP-1 in relation to the total concentration of MCP-1 in biological samples. Also disclosed are a diagnostic kit and a method for screening a glutaminyl cyclase (QC) inhibitor or measuring the effectiveness of a glutaminyl cyclase (QC) inhibitor. | 09-01-2011 |
Nadine Tscholitsch, Hanau DE
Patent application number | Description | Published |
---|---|---|
20150132511 | Composite material, heat-absorbing component, and method for producing the composite material - In a known composite material with a fused silica matrix there are regions of silicon-containing phase embedded. In order to provide a composite material which is suitable for producing components for use in high-temperature processes for heat treatment even when exacting requirements are imposed on impermeability to gas and on purity, it is proposed in accordance with the invention that the composite material be impervious to gas, have a closed porosity of less than 0.5% and a specific density of at least 2.19 g/cm | 05-14-2015 |
Nadine Tuaillon, Sykesville, MD US
Patent application number | Description | Published |
---|---|---|
20110152504 | CD16A Binding Proteins and Use for the Treatment of Immune Disorders - CD 16A binding proteins useful for the reduction of a deleterious immune response asre described. In one aspect, humanized anti-cd16A antibodies, optionally lacking effector function, are used for the treatment of immune disorders such as idiopathic thrombocytopenic purpura and autoimme hemolytic anemia. | 06-23-2011 |
Nadine Tuaillon, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20120276094 | Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same - The present invention relates to molecules comprising a variant Fc region, wherein said variant Fc region comprises at least one amino acid modification relative to a wild-type Fc region, which variant Fc region binds FcγRIIIA and/or FcγRIIA with a greater affinity relative to a comparable molecule comprising the wild-type Fc region. The molecules of the invention are useful in preventing, treating, or ameliorating symptoms associated with a disease, disorder, or infection. The molecules of the invention are particularly useful for the treatment or prevention of a disease or disorder where an enhanced efficacy of effector cell function mediated by FcγR is desired, and in enhancing the therapeutic efficacy of therapeutic antibodies the effect of which is mediated by ADCC. | 11-01-2012 |
Nadine Tuaillon, Gettysburg, PA US
Patent application number | Description | Published |
---|---|---|
20090053218 | FcGammaRIIB Specific Antibodies and Methods of Use Thereof - The present invention relates to antibodies or fragments thereof that specifically bind FcγRIIB, particularly human FcγRIIB, with greater affinity than said antibodies or fragments thereof bind FcγRIIA, particularly human FcγRIIA. The present invention also encompasses the use of an anti-FcγRIIB antibody or an antigen-binding fragment thereof, as a single agent therapy for the treatment, prevention, management, or amelioration of a cancer, preferably a B-cell malignancy, particularly, B-cell chronic lymphocytic leukemia or non-Hodgkin's lymphoma, an autoimmune disorder, an inflammatory disorder, an IgE-mediated allergic disorder, or one or more symptoms thereof. The present invention also encompasses the use of an anti-FcγRIIB antibody or an antigen-binding fragment thereof, in combination with other cancer therapies. The present invention provides pharmaceutical compositions comprising an anti-FcγRIIB antibody or an antigen-binding fragment thereof, in amounts effective to prevent, treat, manage, or ameliorate a cancer, such as a B-cell malignancy, an autoimmune disorder, an inflammatory disorder, an IgE-mediated allergic disorder, or one or more symptoms thereof. The invention further provides methods of enhancing the therapeutic effect of therapeutic antibodies by administering the antibodies of the invention to enhance the effector function of the therapeutic antibodies. The invention also provides methods of enhancing efficacy of a vaccine composition by administering the antibodies of the invention with a vaccine composition. | 02-26-2009 |
20090074771 | FcGammaRIIB Specific Antibodies and Methods of Use Thereof - The present invention relates to antibodies or fragments thereof that specifically bind FcγRIIB, particularly human FcγRIIB, more particularly the extracellular domain of FcγRIIB with greater affinity than said antibodies or fragments thereof bind FcγRIIA, particularly human FcγRIIA, and block the Fc binding site of FcγRIIB. The present invention also encompasses the use of an anti-FcγRIIB antibody or an antigen-binding fragment thereof, as a single agent therapy for the treatment, prevention, management, or amelioration of a cancer, preferably a B-cell malignancy, particularly, B-cell chronic lymphocytic leukemia or non-Hodgkin's lymphoma, an autoimmune disorder, an inflammatory disorder, an IgE-mediated allergic disorder, or one or more symptoms thereof. The present invention also encompasses the use of an anti-FcγRIIB antibody or an antigen-binding fragment thereof, in combination with other cancer therapies. The present invention provides pharmaceutical compositions comprising an anti-FcγRIIB antibody or an antigen-binding fragment thereof, in amounts effective to prevent, treat, manage, or ameliorate a cancer, such as a B-cell malignancy, an autoimmune disorder, an inflammatory disorder, an IgE-mediated allergic disorder, or one or more symptoms thereof. The invention further provides methods of enhancing the therapeutic effect of therapeutic antibodies by administering the antibodies of the invention to enhance the effector function of the therapeutic antibodies. The invention also provides methods of enhancing efficacy of a vaccine composition by administering the antibodies of the invention with a vaccine composition. The invention further provides methods of treating cancer and/or regulating immune complex-mediated cell activation by administering the antibodies of the invention to enhance an immune response. The invention also provides methods of breaking tolerance to an antigen by administering an antigen-antibody complex and an antibody of the invention. | 03-19-2009 |
20090076251 | FcGammaRIIB Specific Antibodies and Methods of Use Thereof - The present invention relates to antibodies or fragments thereof that specifically bind FcγRIIB, particularly human FcγRIIB, more particularly the extracellular domain of FcγRIIB with greater affinity than said antibodies or fragments thereof bind FcγRIIA, particularly human FcγRIIA, and block the Fc binding site of FcγRIIB. The present invention also encompasses the use of an anti-FcγRIIB antibody or an antigen-binding fragment thereof, as a single agent therapy for the treatment, prevention, management, or amelioration of a cancer, preferably a B-cell malignancy, particularly, B-cell chronic lymphocytic leukemia or non-Hodgkin's lymphoma, an autoimmune disorder, an inflammatory disorder, an IgE-mediated allergic disorder, or one or more symptoms thereof. The present invention also encompasses the use of an anti-FcγRIIB antibody or an antigen-binding fragment thereof, in combination with other cancer therapies. The present invention provides pharmaceutical compositions comprising an anti-FcγRIIB antibody or an antigen-binding fragment thereof, in amounts effective to prevent, treat, manage, or ameliorate a cancer, such as a B-cell malignancy, an autoimmune disorder, an inflammatory disorder, an IgE-mediated allergic disorder, or one or more symptoms thereof. The invention further provides methods of enhancing the therapeutic effect of therapeutic antibodies by administering the antibodies of the invention to enhance the effector function of the therapeutic antibodies. The invention also provides methods of enhancing efficacy of a vaccine composition by administering the antibodies of the invention with a vaccine composition. The invention further provides methods of treating cancer and/or regulating immune complex-mediated cell activation by administering the antibodies of the invention to enhance an immune response. The invention also provides methods of breaking tolerance to an antigen by administering an antigen-antibody complex and an antibody of the invention. | 03-19-2009 |
20090092610 | FcGammaRIIB Specific Antibodies and Methods of Use Thereof - The present invention relates to antibodies or fragments thereof that specifically bind the extracellular domain of FcγRIIB, particularly human FcγRIIB, and block the Fc binding site of human FcγRIIB. The invention provides methods of treating cancer and/or regulating immune complex-mediated cell activation by administering the antibodies of the invention to enhance an immune response. The invention also provides methods of breaking tolerance to an antigen by administering an antigen-antibody complex and an antibody of the invention. | 04-09-2009 |
20090191195 | Combination of FcgammaRIIB-Specific Antibodies and CD20-Specific Antibodies and Methods of Use Thereof - The present invention relates to methods of treatment, prevention, management or amelioration of one or more symptoms of diseases or disorders associated with CD20 expression that encompass administration of a combination of: (A) one or more antibodies that specifically bind FcγRIIB, particularly human FcγRIIB, with greater affinity than said antibodies bind FcγRIIA, and (B) one or more antibodies that specifically bind to CD20. Such methods include methods of treating, preventing, managing or ameliorating one or more symptoms of a B cell related disease or disorder or an inflammatory disorder. The invention also provides pharmaceutical compositions comprising an anti-FcγRIIB antibody and an anti-CD20 antibody. | 07-30-2009 |
20100196372 | FcgammaRIIB Fusion Proteins and Compositions Thereof - The present invention relates to molecules, preferably soluble (i.e., not membrane bound) polypeptides, most preferably soluble fusion polypeptides comprising the extracellular soluble regions of an FcγR, derivatives and analogs thereof, and nucleic acids encoding same. Molecules of the invention are particularly useful for the treatment, management, or prevention of, or amelioration of one or more symptoms of, an autoimmune disease, especially for ameliorating serum platelet deficiency associated with immune thrombocytopenic purpura. The invention provides methods and compositions for enhancing the therapeutic efficacy of standard, current or experimental therapies for an autoimmune disease by administering a molecule of the invention. | 08-05-2010 |
20110097323 | Her2/neu-Specific Antibodies and Methods of Using Same - This invention relates to antibodies that specifically bind HER2/neu, and particularly chimeric 4D5 antibodies to HER2/neu, which have reduced glycosylation as compared to known 4D5 antibodies. The invention also relates to methods of using the 4D5 antibodies and compositions comprising them in the diagnosis, prognosis and therapy of diseases such as cancer, autoimmune diseases, inflammatory disorders, and infectious disease. | 04-28-2011 |
20120034221 | T-Cell Receptor Antibodies And Methods of Use Thereof - The present invention is directed to the production and use of monoclonal antibodies, or antigen binding fragments thereof, that specifically bind the T cell antigen receptor (TCR) and their use for immunomodulation. In preferred embodiments, the antibody or antigen binding fragment of the invention specifically binds the constant region of the α chain of the TCR, or otherwise specifically binds the α chain regardless of TCR clonal origin (i.e., is pan specific for TCR). The antibodies of the invention may be used, for example, in immunosuppressive therapies for transplant maintenance and the treatment of autoimmune diseases, and/or as targeting molecules for use in the treatment of T-cell malignancies. | 02-09-2012 |
20140328836 | HER2/neu-Specific Antibodies and Methods of Using Same - This invention relates to antibodies that specifically bind HER2/neu, and particularly chimeric 4D5 antibodies to HER2/neu, which have reduced glycosylation as compared to known 4D5 antibodies. The invention also relates to methods of using the 4D5 antibodies and compositions comprising them in the diagnosis, prognosis and therapy of diseases such as cancer, autoimmune diseases, inflammatory disorders, and infectious disease. | 11-06-2014 |
20140328843 | Combination of FcgammaRIIB-Specific Antibodies and CD20-Specific Antibodies and Methods of Use Thereof - The present invention relates to methods of treatment, prevention, management or amelioration of one or more symptoms of diseases or disorders associated with CD20 expression that encompass administration of a combination of: (A) one or more antibodies that specifically bind FcγRIIB, particularly human FcγRIIB, with greater affinity than said antibodies bind FcγRIIA, and (B) one or more antibodies that specifically bind to CD20. Such methods include methods of treating, preventing, managing or ameliorating one or more symptoms of a B cell related disease or disorder or an inflammatory disorder. The invention also provides pharmaceutical compositions comprising an anti-FcγRIIB antibody and an anti-CD20 antibody. | 11-06-2014 |
Nadine Varin-Blank, Sartrouville FR
Patent application number | Description | Published |
---|---|---|
20090258385 | METHOD OF ANALYZING CELLS BY FLOW CYTOMETRY, USE OF AN ANTIOXIDANT AND/OR FREE RADICAL-SCAVENGING AGENT IN SUCH A METHOD AND INCUBATION BUFFER COMPRISING AN ANTIOXIDANT AND/OR FREE RADICAL-SCAVENGING AGENT - The invention relates to a method of analyzing cells by flow cytometry and the use of an antioxidant and/or free radical-scavenging agent in such a method. It also relates to an incubation buffer comprising an antioxidant and/or free radical-scavenging agent. The method of the invention comprises a step for labeling cells in a labeling solution comprising an incubation buffer and the labeling antibody or antibodies conjugated with at least one fluorochrome which is an APC tandem and an antioxidant and/or free radical-scavenging agent. The invention finds application in the field of the analysis of cells by flow cytometry, in particular. | 10-15-2009 |
Nadine Warkotsch, Munchen DE
Patent application number | Description | Published |
---|---|---|
20120156377 | AGENT FOR TREATING HARD SURFACES - The present invention is an agent for treating a hard surface comprising at least two components selected from the group consisting of (a) multi-armed stellate polyalkoxylates; (b) polyesteramides; and (c) copolymers prepared from a quaternary ammonium acrylamide and acrylic acid. The agents of the present invention find use in cleaning hard surfaces and/or providing a soil-repellant finish to hard surfaces such as ceramic, glass, stainless steel and plastic. | 06-21-2012 |
20120226063 | USE OF SALTS OF BRANCHED FATTY ACIDS AS CATALYSTS FOR CONVERTING STAR-SHAPED ALCOHOLS USING ISOCYANATES - The invention relates to the use of salts of branched fatty acids for catalyzing the reaction between star-shaped alcohols and isocyanates. | 09-06-2012 |
Nadine Worle, Musau AT
Patent application number | Description | Published |
---|---|---|
20090175400 | First-Wall Component for a Fusion Reactor with a Heat Sink of a Copper Alloy - A first-wall component of a fusion reactor has a heat shield and a heat sink. The heat shield is formed of a material from the group of graphite material, carbidic material, tungsten and tungsten alloy. The heat sink is formed of a spray-compacted copper alloy. | 07-09-2009 |